New antiherpes drugs in development
- 1 December 1993
- journal article
- forum
- Published by Wiley in Reviews in Medical Virology
- Vol. 3 (4) , 225-236
- https://doi.org/10.1002/rmv.1980030406
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Synthesis and antiviral activity of 9-alkoxypurines. 2. 9-(2,3-Dihydroxypropoxy)-, 9-(3,4-dihydroxybutoxy)-, and 9-(1,4-dihydroxybut-2-oxy)purinesJournal of Medicinal Chemistry, 1991
- Structure-activity relationships of N2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinasesJournal of Medicinal Chemistry, 1990
- Acyclovir-Resistant Herpes Simplex Virus Infections in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989
- Vidarabine versus Acyclovir Therapy in Herpes Simplex EncephalitisNew England Journal of Medicine, 1986
- Vidarabine Therapy for Mucocutaneous Herpes Simplex Virus Infections in the Immunocompromised HostThe Journal of Infectious Diseases, 1984
- Effects of Interferon-Alpha on Cytomegalovirus Reactivation Syndromes in Renal-Transplant RecipientsNew England Journal of Medicine, 1983
- Early Vidarabine Therapy to Control the Complications of Herpes Zoster in Immunosuppressed PatientsNew England Journal of Medicine, 1982
- Human Leukocyte Interferon for the Treatment of Varicella in Children with CancerNew England Journal of Medicine, 1982
- EFFICACY OF ORAL ACYCLOVIR IN THE TREATMENT OF INITIAL AND RECURRENT GENITAL HERPESPublished by Elsevier ,1982
- Herpes Simplex EncephalitisNew England Journal of Medicine, 1981